US Patent Issued to Pfizer on June 3 for "Immunogenic compositions for use in pneumococcal vaccines" (New York Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,438, issued on June 3, was assigned to Pfizer Inc. (New York).

"Immunogenic compositions for use in pneumococcal vaccines" was invented by David Cooper (Monroe, N.Y.), Kathrin Ute Jansen (New York) and Michael William Pride (Staten Island, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An object of the present invention is to provide immunogenic compositions for protection against S. pneumoniae, in particular against S. pneumoniae serogroup 18, while limiting the number of conjugates. The present invention therefore relates to new immunogenic compositions for use in pneumococcal vaccines and to vaccination of human subjects, in particular infant...